Article Details

Earnings call: Aytu BioPharma reports turnaround with focus on ADHD - Investing.com

Retrieved on: 2024-09-27 19:29:34

Tags for this article:

Click the tags to see associated articles and topics

Earnings call: Aytu BioPharma reports turnaround with focus on ADHD - Investing.com. View article details on hiswai:

Excerpt

Aytu BioPharma (ticker AYTU), in its Fiscal 2024 Q4 Earnings Call, highlighted a year of transformation and strategic refocusing on ADHD and ...

Article found on: www.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo